|
US7445924B2
(en)
*
|
2000-11-23 |
2008-11-04 |
Bavarian Nordic A/S |
Modified Vaccinia Ankara virus variant and cultivation method
|
|
US20060191026A1
(en)
|
2005-02-18 |
2006-08-24 |
Origen Therapeutics, Inc. |
Tissue specific expression of antibodies in chickens
|
|
US7145057B2
(en)
|
2002-02-01 |
2006-12-05 |
Origen Therapeutics, Inc. |
Chimeric bird from embryonic stem cells
|
|
FR2836924B1
(fr)
|
2002-03-08 |
2005-01-14 |
Vivalis |
Lignees de cellules aviaires utiles pour la production de substances d'interet
|
|
AU2003264144C1
(en)
*
|
2002-09-05 |
2009-12-17 |
Bavarian Nordic A/S |
Method for the cultivation of primary cells and for the amplification of viruses under serum free conditions
|
|
AU2003296974A1
(en)
*
|
2002-12-13 |
2004-07-14 |
Aventis Pasteur, Inc. |
Production of alvac on avian embryonic stem cells
|
|
EP1500699A1
(en)
*
|
2003-07-22 |
2005-01-26 |
Vivalis |
Production of vaccinia virus with adherent or non adherent avian cell lines
|
|
KR101121971B1
(ko)
|
2003-07-22 |
2012-03-09 |
비바리스 |
부착성 또는 비부착성 조류 세포주를 이용한폭스바이러스의 생산
|
|
EP1678292A4
(en)
*
|
2003-09-18 |
2008-05-07 |
Univ Emory |
IMPROVED MVA VACCINES
|
|
US20090104226A1
(en)
|
2004-05-21 |
2009-04-23 |
Novartis Vaccines And Diagnostics Inc. |
Alphavirus Vectors for Respiratory Pathogen Vaccines
|
|
RS51665B
(sr)
|
2004-09-09 |
2011-10-31 |
Novartis Vaccines And Diagnostics Gmbh. |
Smanjenje potencijalnih jatrogenih rizika povezanih sa vakcinama protiv gripa
|
|
AU2005314563B2
(en)
|
2004-11-03 |
2011-06-30 |
Seqirus UK Limited |
Influenza vaccination
|
|
FR2878860A1
(fr)
*
|
2004-12-08 |
2006-06-09 |
Vivalis Sa |
Lignees de cellules souches humaines derivees de cellules es et utilisations pour la production de vaccins et de proteines recombinantes
|
|
AU2011253998B2
(en)
*
|
2005-04-11 |
2014-04-24 |
Valneva |
Process of manufacturing viral vaccines in suspension avian embryonic derived stem cell lines
|
|
FR2884255B1
(fr)
*
|
2005-04-11 |
2010-11-05 |
Vivalis |
Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
|
|
ATE494906T1
(de)
|
2005-11-01 |
2011-01-15 |
Novartis Vaccines & Diagnostic |
Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
|
|
WO2007052055A1
(en)
|
2005-11-04 |
2007-05-10 |
Novartis Vaccines And Diagnostics Srl |
Adjuvanted vaccines with non-virion antigens prepared from influenza viruses grown in cell culture
|
|
CA2628424A1
(en)
|
2005-11-04 |
2007-05-10 |
Novartis Vaccines And Diagnostics S.R.L. |
Adjuvanted influenza vaccines including cytokine-inducing agents
|
|
KR20080069232A
(ko)
|
2005-11-04 |
2008-07-25 |
노바티스 백신즈 앤드 다이아그노스틱스 에스.알.엘. |
스플리트 인플루엔자 백신에 대한 보조제로서 유리 수성상계면활성제를 갖는 에멀젼
|
|
NZ594482A
(en)
|
2005-11-04 |
2012-11-30 |
Novartis Vaccines & Diagnostic |
Influenza vaccines with reduced amount of oil-in-water emulsion as adjuvant
|
|
ES2377884T3
(es)
|
2005-11-04 |
2012-04-02 |
Novartis Vaccines And Diagnostics S.R.L. |
Vacunas contra la gripe que incluyen combinaciones de adyuvantes particulados e inmunopotenciadores
|
|
PL2478916T3
(pl)
|
2006-01-27 |
2020-11-16 |
Seqirus UK Limited |
Szczepionki przeciw grypie zawierające hemaglutyninę i białka macierzy
|
|
FR2898909A1
(fr)
|
2006-03-24 |
2007-09-28 |
Agronomique Inst Nat Rech |
Combinaison de marqueurs de cellules aviaires
|
|
WO2007110776A1
(en)
|
2006-03-24 |
2007-10-04 |
Novartis Vaccines And Diagnostics Gmbh & Co Kg |
Storage of influenza vaccines without refrigeration
|
|
GB0614460D0
(en)
|
2006-07-20 |
2006-08-30 |
Novartis Ag |
Vaccines
|
|
WO2008017704A1
(en)
|
2006-08-09 |
2008-02-14 |
Vivalis |
Method of production of transgenic avian using embryonic stem cells
|
|
NZ575271A
(en)
|
2006-09-11 |
2011-09-30 |
Novartis Ag |
Making influenza virus vaccines without using eggs
|
|
JP2011506264A
(ja)
|
2006-12-06 |
2011-03-03 |
ノバルティス アーゲー |
インフルエンザウイルスの4つの株に由来する抗原を含むワクチン
|
|
CN100443588C
(zh)
*
|
2006-12-11 |
2008-12-17 |
中国农业科学院北京畜牧兽医研究所 |
静宁鸡胚成纤维细胞系及其培养方法
|
|
EP1985305A1
(en)
|
2007-04-24 |
2008-10-29 |
Vivalis |
Duck embryonic derived stem cell lines for the production of viral vaccines
|
|
EP1995309A1
(en)
*
|
2007-05-21 |
2008-11-26 |
Vivalis |
Recombinant protein production in avian EBx® cells
|
|
PT2185191E
(pt)
|
2007-06-27 |
2012-11-27 |
Novartis Ag |
Vacinas contra a gripe com baixo teor de aditivos
|
|
BRPI0811787B1
(pt)
*
|
2007-07-03 |
2018-10-09 |
Transgene Sa |
usos de uma célula imortalizada e processo para imortalizar uma célula aviária
|
|
US20090028831A1
(en)
*
|
2007-07-23 |
2009-01-29 |
University Of Kentucky Research Foundation |
Stem cell regulator, compositions and methods of use
|
|
GB0810305D0
(en)
|
2008-06-05 |
2008-07-09 |
Novartis Ag |
Influenza vaccination
|
|
EP2235532B1
(en)
|
2007-12-24 |
2013-04-24 |
Novartis AG |
Assays for adsorbed influenza vaccines
|
|
US8506966B2
(en)
|
2008-02-22 |
2013-08-13 |
Novartis Ag |
Adjuvanted influenza vaccines for pediatric use
|
|
KR20140096162A
(ko)
|
2008-02-25 |
2014-08-04 |
백스터 인터내셔널 인코포레이티드 |
연속 세포주 제조 방법
|
|
JP5518041B2
(ja)
|
2008-03-18 |
2014-06-11 |
ノバルティス アーゲー |
インフルエンザウイルスワクチン抗原の調製における改良
|
|
US8716016B2
(en)
*
|
2008-04-23 |
2014-05-06 |
Board Of Trustees Of Michigan State University |
Immortal avian cell line and methods of use
|
|
EP2379598B1
(en)
|
2009-01-19 |
2015-03-11 |
Innate Pharma |
Anti-kir3d antibodies
|
|
JP2012517416A
(ja)
|
2009-02-10 |
2012-08-02 |
ノバルティス アーゲー |
増加した量のh3抗原を含むインフルエンザワクチン
|
|
WO2010092476A1
(en)
|
2009-02-10 |
2010-08-19 |
Novartis Ag |
Influenza vaccine regimens for pandemic-associated strains
|
|
EA023662B1
(ru)
|
2009-02-10 |
2016-06-30 |
Новартис Аг |
Вакцины против гриппа со сниженным количеством сквалена
|
|
DE102010018462A1
(de)
|
2009-04-27 |
2011-04-07 |
Novartis Ag |
Impfstoffe zum Schutz gegen Influenza
|
|
EP4183412B1
(en)
|
2009-07-15 |
2024-08-14 |
GlaxoSmithKline Biologicals SA |
Rsv f protein compositions and methods for making same
|
|
CN102695523A
(zh)
|
2009-09-10 |
2012-09-26 |
诺华有限公司 |
针对呼吸道疾病的组合疫苗
|
|
GB0918830D0
(en)
|
2009-10-27 |
2009-12-09 |
Glaxosmithkline Biolog Niederl |
Process
|
|
GB0919117D0
(en)
*
|
2009-10-30 |
2009-12-16 |
Glaxosmithkline Biolog Sa |
Process
|
|
CA2725435C
(en)
|
2009-12-15 |
2023-01-03 |
University Of Saskatchewan |
Vaccines for inclusion body hepatitis
|
|
WO2011095596A1
(en)
|
2010-02-04 |
2011-08-11 |
Vivalis |
Fed-batch process using concentrated cell culture medium for the efficient production of biologics in eb66 cells
|
|
FR2956409A1
(fr)
|
2010-02-15 |
2011-08-19 |
Univ Claude Bernard Lyon |
Procedes pour optimiser la production virale par l'inactivation ou l'inhibition du gene hipk2 et cellules modifiees pour la production virale
|
|
CA2792469A1
(en)
|
2010-03-08 |
2011-09-15 |
Novartis Ag |
Methods of testing for intracellular pathogens
|
|
US9744228B2
(en)
|
2010-04-07 |
2017-08-29 |
Norvartis Ag |
Method for generating a parvovirus B19 virus-like particle
|
|
US9441032B2
(en)
|
2010-04-07 |
2016-09-13 |
Agency For Science, Technology And Research |
Binding molecules against Chikungunya virus and uses thereof
|
|
EP2374816B1
(en)
|
2010-04-07 |
2016-09-28 |
Agency For Science, Technology And Research |
Binding molecules against Chikungunya virus and uses thereof
|
|
JP6072677B2
(ja)
|
2010-05-06 |
2017-02-01 |
ノバルティス アーゲー |
微生物の不活化のための有機ペルオキシド化合物
|
|
JP5876036B2
(ja)
|
2010-05-21 |
2016-03-02 |
ノバルティス アーゲー |
インフルエンザウイルス再集合方法
|
|
CA2801151A1
(en)
|
2010-06-01 |
2011-12-08 |
Novartis Ag |
Concentration of vaccine antigens with lyophilization
|
|
PL2575872T3
(pl)
|
2010-06-01 |
2021-02-22 |
Seqirus UK Limited |
Zatężanie antygenów szczepionkowych grypy bez liofilizacji
|
|
CA2804501C
(en)
|
2010-07-06 |
2021-01-26 |
Novartis Ag |
Noro virus derived immunogenic compositions and methods
|
|
GB201011502D0
(en)
|
2010-07-08 |
2010-08-25 |
Glaxosmithkline Biolog Sa |
Novel process
|
|
CA2808965C
(en)
|
2010-08-20 |
2020-01-07 |
Theraject, Inc. |
Soluble needle arrays for delivery of influenza vaccines
|
|
CA3150342A1
(en)
|
2010-09-07 |
2012-03-15 |
Technion Research & Development Foundation Limited |
Novel methods and culture media for culturing pluripotent stem cells
|
|
FR2967072B1
(fr)
|
2010-11-05 |
2013-03-29 |
Univ Dundee |
Procede pour ameliorer la production de virus et semences vaccinales influenza
|
|
WO2012095514A1
(en)
|
2011-01-14 |
2012-07-19 |
Vivalis |
Recombinant protein production system
|
|
ES3018416T3
(es)
|
2011-01-26 |
2025-05-16 |
Glaxosmithkline Biologicals Sa |
Régimen de inmunización del VRS
|
|
RS56748B1
(sr)
|
2011-05-13 |
2018-03-30 |
Glaxosmithkline Biologicals Sa |
Pre-fuzioni rsv f antigeni
|
|
JP2014522842A
(ja)
|
2011-07-06 |
2014-09-08 |
ノバルティス アーゲー |
免疫原性組み合わせ組成物およびその使用
|
|
US11058762B2
(en)
|
2011-07-06 |
2021-07-13 |
Glaxosmithkline Biologicals Sa |
Immunogenic compositions and uses thereof
|
|
TWI575070B
(zh)
|
2011-07-12 |
2017-03-21 |
傳斯堅公司 |
Hbv聚合酶突變體
|
|
TW201318637A
(zh)
|
2011-09-29 |
2013-05-16 |
Transgene Sa |
免疫療法組成物及用於治療c型肝炎病毒感染之療程(一)
|
|
WO2013045668A2
(en)
|
2011-09-29 |
2013-04-04 |
Transgene Sa |
Immunotherapy composition and regimen for treating hepatitis c virus infection
|
|
US20140348863A1
(en)
|
2011-10-12 |
2014-11-27 |
Alessia Bianchi |
Cmv antigens and uses thereof
|
|
GB201216121D0
(en)
|
2012-09-10 |
2012-10-24 |
Novartis Ag |
Sample quantification by disc centrifugation
|
|
EP2768528A1
(en)
|
2011-10-20 |
2014-08-27 |
Novartis AG |
Adjuvanted influenza b virus vaccines for pediatric priming
|
|
EP2660316A1
(en)
|
2012-05-02 |
2013-11-06 |
Helmholtz-Zentrum für Infektionsforschung GmbH |
Avian cell line and its use in production of protein
|
|
EP2869842A1
(en)
|
2012-07-06 |
2015-05-13 |
Novartis AG |
Immunogenic compositions and uses thereof
|
|
WO2014009433A1
(en)
|
2012-07-10 |
2014-01-16 |
Transgene Sa |
Mycobacterium resuscitation promoting factor for use as adjuvant
|
|
SG11201500171YA
(en)
|
2012-07-10 |
2015-02-27 |
Transgene Sa |
Mycobacterial antigen vaccine
|
|
GB201218195D0
(en)
|
2012-10-10 |
2012-11-21 |
Istituto Zooprofilattico Sperimentale Delle Venezie |
Composition
|
|
KR20150085843A
(ko)
|
2012-11-20 |
2015-07-24 |
글락소스미스클라인 바이오로지칼즈 에스.에이. |
Rsv f 융합전 삼합체
|
|
US20140255447A1
(en)
*
|
2013-03-05 |
2014-09-11 |
Biomune Company |
Production of avian embryo cells
|
|
FR3008992A1
(fr)
*
|
2013-07-25 |
2015-01-30 |
Agronomique Inst Nat Rech |
Procede de selection d'une lignee cellulaire permissive pour la replication de virus aviaires
|
|
EP3092000A1
(en)
|
2014-01-09 |
2016-11-16 |
Transgene SA |
Fusion of heterooligomeric mycobacterial antigens
|
|
EP2974739A1
(en)
|
2014-07-15 |
2016-01-20 |
Novartis AG |
RSVF trimerization domains
|
|
EP3031822A1
(en)
|
2014-12-08 |
2016-06-15 |
Novartis AG |
Cytomegalovirus antigens
|
|
US11118238B2
(en)
|
2014-12-17 |
2021-09-14 |
Fundación Para La Investigación Mèdica Aplicada |
Nucleic acid constructs and gene therapy vectors for use in the treatment of Wilson's disease and other conditions
|
|
CN107208105A
(zh)
|
2014-12-17 |
2017-09-26 |
基础应用医学研究基金会 |
用于治疗威尔森病的核酸构建体和基因治疗载体
|
|
EP3047856A1
(en)
|
2015-01-23 |
2016-07-27 |
Novartis AG |
Cmv antigens and uses thereof
|
|
KR20180035807A
(ko)
|
2015-06-26 |
2018-04-06 |
세퀴러스 유케이 리미티드 |
항원적으로 매치된 인플루엔자 백신
|
|
AU2016290603B2
(en)
|
2015-07-07 |
2022-06-02 |
Seqirus UK Limited |
Influenza potency assays
|
|
CN110506060B
(zh)
|
2017-03-30 |
2024-05-07 |
昆士兰大学 |
嵌合分子及其用途
|
|
CN117821509A
(zh)
|
2017-04-03 |
2024-04-05 |
编码治疗公司 |
组织选择性转基因表达
|
|
WO2019040994A1
(en)
|
2017-09-01 |
2019-03-07 |
The Australian National University |
IMMUNOREGULATOR MOLECULES AND USES THEREOF
|
|
CN118345115A
(zh)
|
2017-12-01 |
2024-07-16 |
编码治疗公司 |
工程化的dna结合蛋白
|
|
EP3794127A1
(en)
|
2018-05-14 |
2021-03-24 |
Vivet Therapeutics |
Gene therapy vectors comprising s/mar sequences
|
|
CN112384627A
(zh)
|
2018-05-30 |
2021-02-19 |
生物医学研究所 |
通过利用内源激活诱导性胞嘧啶脱氨酶改造b淋巴细胞
|
|
EP3820884B1
(en)
|
2018-07-13 |
2025-09-03 |
Valneva SE |
Method for rescuing and producing a virus in avian cells
|
|
AU2019356165A1
(en)
|
2018-10-12 |
2021-05-27 |
Vivet Therapeutics |
Codon-optimized transgene for the treatment of progressive familiar intrahepatic cholestasis type 3 (PFIC3)
|
|
SG11202104634UA
(en)
|
2018-11-07 |
2021-06-29 |
Vivet Therapeutics |
Codon-optimized abcb11 transgene for the treatment of progressive familial intrahepatic cholestasis type 2 (pfic2)
|
|
CA3118936A1
(en)
|
2018-11-16 |
2020-05-22 |
Encoded Therapeutics, Inc. |
Compositions and methods for treating wilson's disease
|
|
BR112021009793A2
(pt)
*
|
2018-11-23 |
2021-08-17 |
Valneva Se |
produtos alimentícios que compreendem células-tronco aviárias
|
|
US12467038B2
(en)
|
2019-05-22 |
2025-11-11 |
Hadasit Medical Research Services And Development Ltd. |
Methods of culturing human pluripotent cells
|
|
SG11202113048SA
(en)
|
2019-05-29 |
2021-12-30 |
Encoded Therapeutics Inc |
Compositions and methods for selective gene regulation
|
|
WO2021001377A1
(en)
|
2019-07-02 |
2021-01-07 |
Fundacion Para La Investigacion Medica Aplicada |
cPLA2e INDUCING AGENTS AND USES THEREOF
|
|
MX2022000879A
(es)
|
2019-07-21 |
2022-05-02 |
Glaxosmithkline Biologicals Sa |
Vacuna viral terapeutica.
|
|
EP4004018A1
(en)
|
2019-07-24 |
2022-06-01 |
GlaxoSmithKline Biologicals SA |
Modified human cytomegalovirus proteins
|
|
AU2020344163A1
(en)
*
|
2019-09-10 |
2022-03-31 |
Vital Meat |
Avian stem cells for the production of a food product
|
|
EP4061930A1
(en)
|
2019-11-18 |
2022-09-28 |
Seqirus Pty Ltd |
Method for producing reassortant influenza viruses
|
|
CA3181024A1
(en)
|
2020-08-06 |
2022-02-10 |
Fundacion Para La Investigacion Medica Aplicada |
Viral particles for use in treating tauopathies such as alzheimer's diseases by gene therapy
|
|
US20230265456A1
(en)
|
2020-08-10 |
2023-08-24 |
Fundacion Para La Investigacion Medica Aplicada |
Gene therapy vector expressing cyp27a1 for the treatment of cerebrotendinous xanthomatosis
|
|
IL301255A
(en)
|
2020-10-09 |
2023-05-01 |
UCB Biopharma SRL |
Nucleic acid structures, viral vectors and viral particles
|
|
US20240091382A1
(en)
|
2020-12-23 |
2024-03-21 |
Vivet Therapeutics |
Minimal bile acid inducible promoters for gene therapy
|
|
EP4032547A1
(en)
|
2021-01-20 |
2022-07-27 |
GlaxoSmithKline Biologicals S.A. |
Hsv1 fce derived fragements for the treatment of hsv
|
|
IL312340A
(en)
|
2021-10-28 |
2024-06-01 |
UCB Biopharma SRL |
Nucleic acid constructs, viral vectors and viral particles
|
|
US20250101067A1
(en)
|
2022-01-28 |
2025-03-27 |
Glaxosmithkline Biologicals Sa |
Modified human cytomegalovirus proteins
|
|
CN114480286B
(zh)
*
|
2022-02-16 |
2024-05-31 |
上海健士拜生物科技有限公司 |
无血清悬浮型lmh细胞系及其制备方法和应用
|
|
CN116656628A
(zh)
*
|
2023-07-31 |
2023-08-29 |
深圳市卫光生物制品股份有限公司 |
一种痘病毒载体疫苗的制备方法
|
|
EP4567102A1
(en)
|
2023-12-05 |
2025-06-11 |
Suprême |
Methods for isolating embryonic stem cells from avian embryonic cells
|
|
CN118956737A
(zh)
*
|
2024-07-17 |
2024-11-15 |
广州沃亘生物科技有限公司 |
一种长期维持df-1细胞活力的培养基及其用途
|